The United States Food and Drug Administration on Tuesday said that it has approved the first COVID-19 self-testing kit for individuals to test at home. The self-testing kit provides results within 30 minutes which makes it efficient to use.
“While COVID-19 diagnostic tests have been authorized for at-home collection, this is the first that can be fully self-administered and provide results at home,” said Stephen Hahn, Commissioner, FDA.
Lucira Health’s single-use testing kit is given in emergency use authorization to use at home added with self-collecting nasal swab samples for individuals of age 14 and older, who are suspected by health care provider to be infected from Covid-19, the FDA said.
“We look forward to proactively working with test developers to support the availability of more at-home test options,” said Jeff Shuren, Director Center for Devices and Radiological Health, FDA.
The self-testing kit can also be used at hospitals but the samples of individuals younger than 14 years should be collected by healthcare provider, the health regulator said. Recently, the positive news from Moderna Inc. and Pfizer Inc. has raised hopes for potential vaccine in combating the disease. 
On Sunday, US has crossed 11 million total infected cases in just 8 days after reaching mark of 10 million cases.